LEGALIZING MARIJUANA FOR MEDICAL REASONS SENDS WRONG MESSAGE TO YOUTH

Marijuana is the most commonly used illegal drug in America. According
to a national survey performed by the Department of Health and Human
Services, nearly 95 million Americans over the age of 21 have tried
marijuana at least once. In addition to this alarming statistic, of
the 7.1 million Americans suffering from illegal drug dependence or
abuse, 60 percent abuse marijuana. These facts alone show that our
country is currently struggling to control this substance and make it
very clear that policies must be initiated that will further restrict
access to this drug versus granting permission to obtain the substance.

The FDA - which opposes the use of smoked marijuana - is the federal
agency that certifies what drugs are safe and those that have a
medicinal benefit. While I am a supporter of states' rights, it is
critical that scientific research be conducted to determine what the
ramifications are as a result of smoking a potentially dangerous
substance. In 2006, the FDA declared that marijuana has a high
potential for abuse, and that there is a lack of accepted safety for
its use, even under medical supervision. The very idea of ingesting a
"medicine" by smoking it is counterintuitive.

On Dec. 15, the New Jersey Senate's Health, Human Services and Senior
Citizens Committee favorably reported the "New Jersey Compassionate
Use Medical Marijuana Act" by a 6-1 vote, with two abstentions. The
proposed bill would permit patients, who are diagnosed by a physician
as having a debilitating medical condition, to smoke marijuana either
by cultivating up to six plants themselves or having it provided by a
state-authorized personal caregiver. The legislation would also
empower the Department of Health and Senior Services to establish
alternative treatment centers to produce and dispense marijuana for
medical purposes to those possessing a registry identification card.
Currently, 13 other states permit the use of marijuana for medical
purposes.

The potential for this legislation to become law is ill-advised public
policy. I empathize with the stories described by the bill's
supporters of the relief that smoking marijuana gives those with
debilitating diseases, but I fear that New Jersey would be making a
mistake with unforeseen and unintended consequences if we think we can
systematically control who will have lawful access to a controlled and
dangerous subject. The pitfalls are huge and the opportunity for
misuse and abuse are plentiful.

The Senate committee stated that medical research suggested that
smoking marijuana may alleviate pain or other symptoms associatedwith
certain medical conditions. Yet, there have been no studies conducted
by the United States Food and Drug Administration to substantiate this
claim.

Further, the Multiple Sclerosis Society's Information Sourcebook -
last updated in 2005 - advised that "based on studies to date, it is
the opinion of the National Multiple Sclerosis Society's Medical
Advisory Board that there are currently insufficient data to recommend
marijuana or its derivatives as a treatment for MS. Long-term use of
marijuana may be associated with significant serious side effects."

New Jersey - like the other 13 states - is in the process of
sidestepping the protocol for approving medications. Questions
regarding the use and effectiveness of medicine are for the FDA to
answer, not special interest groups, not individuals, and not the
state Legislature.

I am sensitive to the pain that individuals endure from disease, but
that does not make it appropriate to sanction the medical use of
marijuana. The ends do not justify the means. The implications of this
legislation are far-reaching, with an increased opportunity for abuse.
I am not convinced that a secure system can be put into place that
ensures the responsible production, delivery, and monitoring of
medical marijuana.

Allowing either the patient or their caregiver to possess six
marijuana plants for harvesting, or creating alternative treatment
centers to dispense this product should raise a red flag to those
concerned with making or executing sound public policy. The average
marijuana plant can produce anywhere from 1 to 5 pounds of smokeable
materials per year, resulting in a total harvest of anywhere between 6
to 30 pounds of marijuana. Who will oversee its output and ensure that
patients do not overmedicate, or that the excess production is not
diverted to those who use marijuana for recreational purposes? I would
argue that New Jersey is opening Pandora's box by traveling down this
road.

The Drug Enforcement Administration lists marijuana as a schedule I
drug as classified by the Controlled Substances Act, which defines
drugs in this category as being the most restrictive for use due to
their high potential for abuse and addictiveness. Products in this
category are also found to have no currently accepted medical use in
treatment in the United States. It is not surprising that the DEA does
not endorse the use of smoked marijuana for medical purposes.

What is troubling about this legislation is the message that it sends
to our youth. I have seen firsthand the devastation that drugs and
alcohol bring not only to the individual who uses these products, but
upon their families and friends as well. We should not be in the
position of trying to justify to young people that smoking marijuana
under certain circumstances is permissible, but unlawful and harmful
under others.

While we are a compassionate society, there must be a balance between
alleviating or managing pain, and creating a system that potentially
does more harm than good. The road that medical marijuana legislation
is traveling is laden with many potholes. There are too many
unanswered questions regarding this serious public policy issue to
justify it becoming law. And once the box is opened it will be
difficult to return its contents if things do not work out.